(Q38107959)

29 August 2017

title

PA-824 , moxifloxacin and pyrazinamide combination therapy for tuberculosis (English)

1 reference

29 August 2017

1 reference

1 reference

1 reference

2

Andreas Diacon

1 reference

29 August 2017

Rodney Dawson

1

1 reference

29 August 2017

language of work or name

English

0 references

publication date

21 May 2013

1 reference

Expert Opinion on Investigational Drugs

29 August 2017

published in

1 reference

29 August 2017

volume

22

1 reference

29 August 2017

issue

7

1 reference

29 August 2017

page(s)

927-932

1 reference

Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.801958

The challenge of new drug discovery for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.801958

New regimens for reducing the duration of the treatment of drug-susceptible pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.801958

14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.801958

Metronidazole plus rifampin sterilizes long-term dormant Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.801958

Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.801958

Synthesis and antitubercular activity of 7-(R)- and 7-(S)-methyl-2-nitro-6-(S)-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazines, analogues of PA-824.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.801958

Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.801958

Assessment of the effects of the nitroimidazo-oxazine PA-824 on renal function in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.801958

Early bactericidal activity and pharmacokinetics of PA-824 in smear-positive tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.801958

PA-824 exhibits time-dependent activity in a murine model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.801958

Phase II dose-ranging trial of the early bactericidal activity of PA-824

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.801958

Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.801958

Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.801958

Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.801958

Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.801958

Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.801958

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.801958

10.1517/13543784.2013.801958

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference